Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial).

There was an unexpected borderline significant increase in the chest pain onset to balloon time in the group randomized to cangrelor compared with placebo ( P =0.052), although there was no difference in door to balloon times between the 2 treatment groups (Table 1 ).

also in 11,409 other papers